Restriction endonuclease-mediated real-time digestion-PCR for somatic mutation detection

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Polymerase Chain Reaction (PCR) is vital for clinical diagnostics but struggles with detecting low-abundance somatic mutations amidst wild-type DNA.
• Distinguishing rare mutant cells from abundant wild-type cells in tissue samples presents a significant challenge for current PCR-based methods.

Purpose of the Study:

• To develop and validate a novel, one-step method for the sensitive detection of somatic mutations, even when present in low frequencies.
• To assess the efficacy of the new method in identifying the epidermal growth factor receptor (EGFR) T790M mutation, a key marker for treatment resistance.

Main Methods:

• A novel real-time digestion-PCR (RTD-PCR) technique was developed, integrating PCR with restriction endonuclease digestion in a single reaction.
• The RTD-PCR method utilizes a thermostable restriction enzyme to selectively digest wild-type alleles during PCR, thereby enriching for mutant allele amplification.
• The method's performance was validated by detecting the EGFR T790M mutation in 78 clinical samples, comparing results with Sanger sequencing, TaqMan probe PCR, and Sequenom MassArray.

Main Results:

• The RTD-PCR method successfully and consistently detected seven instances of the T790M mutation across all validation platforms.
• The results from RTD-PCR correlated perfectly with established methods like Sanger sequencing, TaqMan probe PCR, and Sequenom MassArray for T790M detection.
• This demonstrates the high specificity and sensitivity of RTD-PCR for identifying specific point mutations in clinical samples.

Conclusions:

• Real-time digestion-PCR (RTD-PCR) offers a robust and sensitive approach for detecting low-frequency somatic mutations, overcoming limitations of standard PCR.
• The validated RTD-PCR method shows significant potential as a valuable clinical tool for the precise analysis of mutations, such as the EGFR T790M mutation.
• This one-step molecular diagnostic technique simplifies mutation detection and may improve patient treatment strategies by accurately identifying resistance markers.